Modeling the Effect of Kv1.5 Block on the Canine Action Potential

被引:12
作者
Almquist, Joachim [1 ]
Wallman, Mikael [1 ,2 ]
Jacobson, Ingemar [3 ]
Jirstrand, Mats [1 ]
机构
[1] Fraunhofer Chalmers Ctr, Gothenburg, Sweden
[2] Univ Oxford, Comp Lab, Oxford OX1 3QD, England
[3] AstraZeneca R&D, Molndal, Sweden
关键词
2-ISOPROPYL-5-METHYLCYCLOHEXYL DIPHENYLPHOSPHINE OXIDE; I-KUR BLOCKER; ATRIAL-FIBRILLATION; MATHEMATICAL-MODEL; POTASSIUM CHANNEL; SYSTEMS-BIOLOGY; DETERMINANTS; VIVO; REPOLARIZATION; TOOLBOX;
D O I
10.1016/j.bpj.2010.08.062
中图分类号
Q6 [生物物理学];
学科分类号
071011 [生物物理学];
摘要
A wide range of ion channels have been considered as potential targets for pharmacological treatment of atrial fibrillation. The Kv1.5 channel, carrying the I-kur current, has received special attention because it contributes to repolarization in the atria but is absent or weakly expressed in ventricular tissue. The dog serves as an important animal model for electrophysiological studies of the heart and mathematical models of the canine atrial action potential (CAAP) have been developed to study the interplay between ionic currents. To enable more-realistic studies on the effects of Kv1.5 blockers on the CAAP in silico, two continuous-time Markov models of the guarded receptor type were formulated for Kv1.5 and subsequently inserted into the Ramirez-Nattel-Courtemanche model of the CAAP. The main findings were: 1), time- and state-dependent Markov models of open-channel Kv1.5 block gave significantly different results compared to a time- and state-independent model with a down-scaled conductance; 2), the outcome of Kv1.5 block on the macroscopic system variable APD(90) was dependent on the precise mechanism of block; and 3), open-channel block produced a reverse use-dependent prolongation of APD(90). This study suggests that more-complex ion-channel models are a prerequisite for quantitative modeling of drug effects.
引用
收藏
页码:2726 / 2736
页数:11
相关论文
共 33 条
[1]
[Anonymous], 1992, NUMERICAL RECIPES C
[2]
Early class III drugs for the treatment of atrial fibrillation -: Efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat [J].
Blaauw, Y ;
Gögelein, H ;
Tieleman, RG ;
van Hunnik, A ;
Schotten, U ;
Allessie, MA .
CIRCULATION, 2004, 110 (13) :1717-1724
[3]
Multiscale modelling of drug-induced effects on cardiac electrophysiological activity [J].
Brennan, T. ;
Fink, M. ;
Rodriguez, B. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (01) :62-77
[4]
Brennan TP, 2007, IFMBE PROC, V16, P50
[5]
Proarrhythmic and antiarrhythmic actions of ion channel blockers on arrhythmias in the heart: Model study [J].
Chay, TR .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 271 (01) :H329-H356
[6]
Choi BH, 2000, J PHARMACOL EXP THER, V293, P634
[7]
Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model [J].
Courtemanche, M ;
Ramirez, RJ ;
Nattel, S .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (01) :H301-H321
[8]
Binding site of a novel Kv1.5 blocker: A "foot in the door" against atrial fibrillation [J].
Decher, Niels ;
Kumar, Pradeep ;
Gonzalez, Teresa ;
Pirard, Bernard ;
Sanguinetti, Michael C. .
MOLECULAR PHARMACOLOGY, 2006, 70 (04) :1204-1211
[9]
Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels [J].
Delpon, E ;
Valenzuela, C ;
Gay, P ;
Franqueza, L ;
Snyders, DJ ;
Tamargo, J .
CARDIOVASCULAR RESEARCH, 1997, 35 (02) :341-350
[10]
Molecular determinants of Kv1.5 channel block by diphenyl phosphine oxide-1 [J].
Du, Yi-mei ;
Zhang, Xiao-xian ;
Tu, Dan-na ;
Zhao, Ning ;
Liu, Yan-jie ;
Xiao, Hua ;
Sanguinetti, Michael C. ;
Zou, Anruo ;
Liao, Yu-hua .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 48 (06) :1111-1120